1. Home
  2. LPL vs IOVA Comparison

LPL vs IOVA Comparison

Compare LPL & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LPL

LG Display Co Ltd AMERICAN DEPOSITORY SHARES

HOLD

Current Price

$4.01

Market Cap

4.0B

Sector

Technology

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.63

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPL
IOVA
Founded
1985
2007
Country
South Korea
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
1.6B
IPO Year
2004
2008

Fundamental Metrics

Financial Performance
Metric
LPL
IOVA
Price
$4.01
$3.63
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
N/A
$9.11
AVG Volume (30 Days)
1.1M
18.0M
Earning Date
01-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.17
$49.14
Revenue Next Year
$3.24
$51.69
P/E Ratio
$25.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.43
$1.64
52 Week High
$5.67
$5.63

Technical Indicators

Market Signals
Indicator
LPL
IOVA
Relative Strength Index (RSI) 43.46 47.26
Support Level $3.82 $2.02
Resistance Level $4.45 $4.34
Average True Range (ATR) 0.14 0.45
MACD -0.04 -0.14
Stochastic Oscillator 21.62 3.39

Price Performance

Historical Comparison
LPL
IOVA

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing, and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in several countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: